CP 461

TargetMol
Product Code: TAR-T31020
Supplier: TargetMol
CodeSizePrice
TAR-T31020-1mg1mg£227.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31020-5mg5mg£416.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31020-10mg10mg£581.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31020-25mg25mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31020-50mg50mg£1,163.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31020-100mg100mg£1,540.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31020-500mg500mg£3,026.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
CP-461 is a member of a novel class of pro-apoptotic agents that specifically inhibit cyclic GMP phosphodiesterase, but not cyclooxygenase-1 or -2. CP-461 inhibits the growth of a variety of human tumor cell lines in vitro and selectively induces cancer cell lines instead of normal cell apoptosis.
CAS:
227619-96-7
Formula:
C25H22ClFN2O
Molecular Weight:
420.91
Pathway:
Apoptosis|Metabolism
Purity:
0.98
SMILES:
Cl.CC1=C(CC(=O)NCc2ccccc2)c2cc(F)ccc2C1=C/c1ccncc1
Target:
PDE|Apoptosis

References

1. Sun W, Stevenson JP, Gallo JM, Redlinger M, Haller D, Algazy K, Giantonio B, Alila H, O'Dwyer PJ. Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer. Clin Cancer Res. 2002 Oct;8(10):3100-4. PubMed PMID: 12374677.